Heart Test Laboratories Accounts Payable

The latest accounts payable for HSCS is $1M as of July 2026. That compares with $280M in the prior-year period — down 99.6% year over year. Investors often review this figure alongside Heart Test Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, HSCS's accounts payable moved from $280M to $1M — a 99.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Heart Test Laboratories's operating scale or balance-sheet position.

A accounts payable figure of $1M for HSCS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HSCS's accounts payable ($1M), review year-over-year change from $280M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.